Initiating Immunotherapy in the Treatment of Stage IV Cancers in the Month Before Death—A Health Care Disparities Lens-Reference-Cited by-同舟云学术

Initiating Immunotherapy in the Treatment of Stage IV Cancers in the Month Before Death—A Health Care Disparities Lens

Published:2024-03-01 Issue:3 Volume:10 Page:297
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Hoerger Michael¹,Nair Navya²,Malhotra Sonia³

Affiliation:

1. Departments of Psychology and Medicine (Hematology and Oncology), Tulane University, New Orleans, Louisiana

2. Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, LSU Health Sciences Center, New Orleans, Louisiana

3. Section of General Internal Medicine, Geriatrics & Palliative Medicine, Deming Department of Medicine, Tulane School of Medicine, New Orleans, Louisiana

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2813585/jamaoncology_hoerger_2024_ed_230025_1710962828.00374.pdf

Reference15 articles.

1. Cancer statistics, 2023.;Siegel;CA Cancer J Clin,2023

2. American Cancer Society’s report on the status of cancer disparities in the United States, 2021.;Islami;CA Cancer J Clin,2022

3. Immunotherapy initiation at the end of life in patients with metastatic cancer in the US.;Kerekes;JAMA Oncol,2024

4. The need for critical examination of disparities in immunotherapy and targeted therapy use among patients with cancer.;Ashrafzadeh;JAMA Oncol,2021

5. Immune-based cancer treatment: addressing disparities in access and outcomes.;Osarogiagbon;Am Soc Clin Oncol Educ Book,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer center matters for appropriate use of immunotherapy at end of life;Cancer;2024-04-29